• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二酮酸及其生物等排体作为潜在抗菌剂的合成及机理研究。

Synthesis and mechanistic studies of diketo acids and their bioisosteres as potential antibacterial agents.

机构信息

Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India; Department of Chemistry, TNB College, TM Bhagalpur University, Bhagalpur, 812007, India.

Centre for Chemical Biology, Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500607, India.

出版信息

Eur J Med Chem. 2019 Feb 1;163:67-82. doi: 10.1016/j.ejmech.2018.11.053. Epub 2018 Nov 22.

DOI:10.1016/j.ejmech.2018.11.053
PMID:30503944
Abstract

A series of diketo esters and their pertinent bioisosteres were designed and synthesized as potent antibacterial agents by targeting methionine amino peptidases (MetAPs). In the biochemical assay against purified MetAPs from Streptococcus pneumoniae (SpMetAP1a), Mycobacterium tuberculosis (MtMetAP1c), Enterococcus faecalis (EfMetAP1a) and human (HsMetAP1b), compounds 3a, 4a and 5a showed more than 85% inhibition of all the tested MetAPs at 100 μM concentration. Compounds 4a and 5a also exhibited antibacterial potential with MIC values 62.5 μg/mL (S. pneumoniae), 31.25 μg/mL (E. faecalis), 62.5 μg/mL (Escherichia coli) and 62.5 μg/mL (S. pneumoniae), 62.5 μg/mL (E. coli), respectively. Moreover, 5a also significantly inhibited the growth of multidrug resistant E. coli strains at 512 μg/mL conc., while showing no cytotoxic effect towards healthy CHO cells and thus being selected. Growth kinetics study showed significant inhibition of bacterial growth when treated with different conc. of 5a. TEM analysis also displayed vital damage to bacterial cells by 5a at MIC conc. Moreover, significant inhibition of biofilm formation was observed in bacterial cells treated with MIC conc. of 5a as visualized by SEM micrographs. Interestingly, 5a did not cause an alteration in the hemocyte density in Galleria mellonella larvae which is considered in vivo model for antimicrobial studies and was non-toxic up to a conc. of 2.5 mg/mL.

摘要

一系列二酮酯及其相关的生物等排体被设计并合成,作为针对甲硫氨酸氨肽酶(MetAPs)的有效抗菌剂。在针对肺炎链球菌(SpMetAP1a)、结核分枝杆菌(MtMetAP1c)、粪肠球菌(EfMetAP1a)和人(HsMetAP1b)的纯化 MetAP 的生化测定中,化合物 3a、4a 和 5a 在 100µM 浓度下对所有测试的 MetAP 表现出超过 85%的抑制作用。化合物 4a 和 5a 还表现出抗菌潜力,MIC 值分别为 62.5μg/mL(肺炎链球菌)、31.25μg/mL(粪肠球菌)、62.5μg/mL(大肠杆菌)和 62.5μg/mL(肺炎链球菌)、62.5μg/mL(大肠杆菌)。此外,5a 还在 512µg/mL 浓度下显著抑制了多重耐药大肠杆菌菌株的生长,同时对健康 CHO 细胞没有细胞毒性作用,因此被选中。生长动力学研究表明,用不同浓度的 5a 处理时,细菌生长受到显著抑制。TEM 分析还显示,5a 在 MIC 浓度下对细菌细胞造成了严重的损伤。此外,SEM 显微照片显示,用 MIC 浓度的 5a 处理细菌细胞时,生物膜形成明显受到抑制。有趣的是,5a 不会引起大蜡螟幼虫血淋巴密度的改变,大蜡螟幼虫被认为是抗菌研究的体内模型,在 2.5mg/mL 浓度下是非毒性的。

相似文献

1
Synthesis and mechanistic studies of diketo acids and their bioisosteres as potential antibacterial agents.二酮酸及其生物等排体作为潜在抗菌剂的合成及机理研究。
Eur J Med Chem. 2019 Feb 1;163:67-82. doi: 10.1016/j.ejmech.2018.11.053. Epub 2018 Nov 22.
2
Design, Synthesis and Mechanistic Studies of Novel Isatin-Pyrazole Hydrazone Conjugates as Selective and Potent Bacterial MetAP Inhibitors.新型异吲哚酮-吡唑腙共轭物作为选择性强效细菌甲硫氨酸氨肽酶抑制剂的设计、合成及作用机制研究
Antibiotics (Basel). 2022 Aug 19;11(8):1126. doi: 10.3390/antibiotics11081126.
3
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituents.新型 2,4-二取代喹唑啉类化合物作为具有改善的细胞毒性特征的抗菌剂:2,4-取代基的优化。
Bioorg Chem. 2021 Dec;117:105422. doi: 10.1016/j.bioorg.2021.105422. Epub 2021 Oct 12.
4
Natural Product-Based 1,2,3-Triazole/Sulfonate Analogues as Potential Chemotherapeutic Agents for Bacterial Infections.基于天然产物的1,2,3-三唑/磺酸盐类似物作为细菌感染的潜在化疗药物。
ACS Omega. 2018 Jun 30;3(6):6912-6930. doi: 10.1021/acsomega.8b00582. Epub 2018 Jun 26.
5
Synthesis, antioxidant and antimicrobial evaluation of simple aromatic esters of ferulic acid.阿魏酸简单芳香酯的合成、抗氧化和抗菌评价。
Arch Pharm Res. 2011 Aug;34(8):1251-61. doi: 10.1007/s12272-011-0803-y. Epub 2011 Sep 11.
6
Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.针对生物膜中耐药革兰氏阴性菌的抗菌萘醌衍生物。
Microb Pathog. 2018 May;118:105-114. doi: 10.1016/j.micpath.2018.03.024. Epub 2018 Mar 14.
7
Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.新型具有广谱抗菌活性的阳离子查尔酮衍生物的合成与抗菌评价。
Eur J Med Chem. 2018 Jan 1;143:905-921. doi: 10.1016/j.ejmech.2017.12.009. Epub 2017 Dec 5.
8
Design, synthesis and evaluation of dihydrotriazine derivatives-bearing 5-aryloxypyrazole moieties as antibacterial agents.含 5-芳氧吡唑基二氢三嗪衍生物的设计、合成与评价及其作为抗菌剂的研究。
Mol Divers. 2021 May;25(2):861-876. doi: 10.1007/s11030-020-10071-9. Epub 2020 Mar 14.
9
Synthesis and antibacterial activity of O-substituted nocathiacin I derivatives.O-取代诺卡硫霉素I衍生物的合成及其抗菌活性
Bioorg Med Chem Lett. 2004 Jul 16;14(14):3743-6. doi: 10.1016/j.bmcl.2004.04.102.
10
Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.在新型萘醌化合物中寻找针对细菌生物膜的潜在抗菌先导结构。
J Appl Microbiol. 2017 Mar;122(3):651-662. doi: 10.1111/jam.13369. Epub 2017 Jan 25.

引用本文的文献

1
Design, Synthesis and Mechanistic Studies of Novel Isatin-Pyrazole Hydrazone Conjugates as Selective and Potent Bacterial MetAP Inhibitors.新型异吲哚酮-吡唑腙共轭物作为选择性强效细菌甲硫氨酸氨肽酶抑制剂的设计、合成及作用机制研究
Antibiotics (Basel). 2022 Aug 19;11(8):1126. doi: 10.3390/antibiotics11081126.
2
Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-Oxazolidinone Derivatives as Antibacterial Agents.3-(吡啶-3-基)-2-恶唑烷酮衍生物作为抗菌剂的合成及生物学评价
Front Chem. 2022 Jul 18;10:949813. doi: 10.3389/fchem.2022.949813. eCollection 2022.
3
Design, Synthesis, and Biological Evaluation of Novel Fused Spiro-4-Pyran Derivatives as Bacterial Biofilm Disruptor.
新型稠合螺-4-吡喃衍生物作为细菌生物膜破坏剂的设计、合成及生物学评价
ACS Omega. 2019 Sep 30;4(16):16794-16807. doi: 10.1021/acsomega.9b01571. eCollection 2019 Oct 15.